A retrospective evaluation of catheter ablation in atrial flutter post cardiac transplantation

Clin Transplant. 2021 Oct;35(10):e14429. doi: 10.1111/ctr.14429. Epub 2021 Jul 22.

Abstract

Background: Atrial flutter is the most common arrhythmia post cardiac transplantation. Observational studies in the non-transplant population have shown prognostic benefit with catheter ablation; however, there are no data in the heart transplant population.

Objectives: This study evaluated the experience of catheter ablation in atrial flutter post cardiac transplantation.

Methods: A retrospective review of experience of late onset atrial flutter at the Freeman Hospital, Newcastle-upon-Tyne, UK, between 1985 and January 2020.

Results: Sixty eight of the 722 patients who survived 6 months post cardiac transplantation developed late atrial flutter giving an incidence of 9.4%. Thirty-two patients were managed with ablation with treatment largely determined by time of flutter onset. Kaplan Meier estimates for arrhythmia free survival post first ablation for organized atrial arrhythmias was 83.3% at 1 year. Kaplan-Meier estimates for median survival post onset of atrial arrhythmias treated with ablation was 11.34 years (95% CI 8.00-14.57), compared to 5.79 years in patients managed medically (95%CI 2.26-9.32) (P = .026).

Conclusions: Atrial flutter is an important late complication of cardiac transplantation. Patients treated with ablation in the modern era had increased survival compared to a historical cohort.

Keywords: cardiovascular disease; clinical decision-making; comorbidities; complication; heart (allograft) function/dysfunction.

MeSH terms

  • Atrial Fibrillation* / surgery
  • Atrial Flutter* / etiology
  • Atrial Flutter* / surgery
  • Catheter Ablation* / adverse effects
  • Heart Transplantation* / adverse effects
  • Humans
  • Prognosis
  • Retrospective Studies